Exact Sciences shares fall after beating Street estimates

Exact Sciences Corp. shares fell in the extended session Thursday even after the cancer diagnostics company’s results topped Wall Street estimates. Exact Sciences shares fell 9% after hours. The company reported a fourth-quarter loss of $21.8 million, or 18 cents a share, compared with a loss of $37.2 million, or 34 cents a share, in the year-ago period. Revenue rose to $87.4 million from $35.2 million in the year-ago period. Analysts surveyed by FactSet had estimated a loss of 23 cents a share on revenue of $86.7 million. For the year, Exact Sciences estimated revenue of $420 million to $430 million. Analysts expect revenue of $423.4 million.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Leave a Reply